Enovis CORP — Director's Dealing 2021

Nov 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Colfax CORP (CFX)
CIK: 0001420800
Period of Report: 2021-11-04

Reporting Person: PRYOR DANIEL A (EVP, Strategy & Business Dev.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-04	Common stock, par value $.001	M	16616	$52.02	Acquired	180873	Direct
2021-11-04	Common stock, par value $.001	S	3361	$53.588	Disposed	177512	Direct
2021-11-04	Common stock, par value $.001	S	12955	$54.089	Disposed	164557	Direct
2021-11-04	Common stock, par value $.001	S	300	$54.143	Disposed	164257	Direct
2021-11-05	Common stock, par value $.001	M	7289	$52.02	Acquired	171546	Direct
2021-11-05	Common stock, par value $.001	S	1154	$53.438	Disposed	170392	Direct
2021-11-05	Common stock, par value $.001	S	6045	$54.223	Disposed	164347	Direct
2021-11-05	Common stock, par value $.001	S	90	$54.08	Disposed	164257	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-04	Employee Stock Option (right to buy)	$52.02	M	16616	Disposed	2022-02-15	Common stock, par value $.001 (16616)	Direct
2021-11-05	Employee Stock Option (right to buy)	$52.02	M	7289	Disposed	2022-02-15	Common stock, par value $.001 (7289)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $.001	2312	Indirect
Common stock, par value $.001	1000	Indirect
Common stock, par value $.001	1000	Indirect
Common stock, par value $.001	1000	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.08 to $54.02, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

F3: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.22, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

F4: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.10 to $54.19, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.

F5: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.94, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.

F6: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.04 to $54.43, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.

F7: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 2/16/2015.